Skip to main content
Clinical Trials/NCT06356870
NCT06356870Not yet recruitingNot Applicable

Alveolar Cleft Reconstruction Using BMAC and Allograft vs Iliac Cancellous Bone: A Randomized Clinical Trial.

Cairo University1 site in 1 country20 target enrollmentStarted: June 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
20
Locations
1
Primary Endpoint
bone density

Study Overview

Brief Summary

radiographic and clinical assessment of alveolar cleft grafting using Allograft mixed with BMAC compared to the standard protocol of anterior iliac crest cancellous bone grafting

Detailed Description

In the study group BMAC is collected after processing of bone marrow aspirated from anterior iliac crest using a stab incision and a specialized trocar with no surgical intervention at donor site. The BMAC will be mixed with allow graft and used for alveolar cleft grafting

In the control group the standard protocol for alveolar cleft grafting will be used which is surgical exposure of the anterior iliac crest and harvesting of cancellous bone particles.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • alveolar cleft patients at the mixed dentition phase

Exclusion Criteria

  • patients with previous alveolar grafting intervention

Outcomes

Primary Outcomes

bone density

Time Frame: 6 months

Assessment of bone density at the grafting site from a CT scan using Hounsfild Unit (HU)

Secondary Outcomes

  • Bone gain(6 months)
  • Postoperative donor site morbidity(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Moustafa Ismail Abdelmaksoud

Assistant lecturer

Cairo University

Study Sites (1)

Loading locations...

Similar Trials